Cancún, MexicoSamsung Medison is capturing global attention with its advanced ultrasound diagnostic solutions tailored to women’s health — spanning every stage of life, from fetal development to menopause.
At the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025), Samsung Medison will present its latest innovations under the theme:
“From Challenges to Solutions: Experience the Innovation.”
From Adolescence to Menopause: A Lifelong Ultrasound Solution
A major highlight at ISUOG 2025 is the unveiling of the upgraded HERA Z20, a powerful diagnostic system designed to support comprehensive women’s healthcare throughout all life stages — from adolescent gynecological conditions and fertility, to pregnancy, childbirth, and aging.
Among the most notable enhancements:
- PelvicAssist™: A new AI-powered tool that automatically analyzes key pelvic regions and measures the levator hiatus area using 3D imaging. It assists in diagnosing complex gynecological conditions with greater speed and accuracy.
- Smart Reporting Features: New reporting tools based on standardized clinical guidelines streamline diagnosis and improve consistency:
- Fibroid 2D follows FIGO standards for assessing uterine fibroids.
- IDEA and IETA reporting tools support endometriosis and endometrial tumor evaluations, respectively, enhancing diagnostic workflows and reducing clinician workload.
Additionally, the introduction of the Mini ER7 probe — 63% smaller than conventional transducers — significantly reduces patient discomfort during gynecological exams, especially for adolescents and elderly patients.
“HERA Z20 is designed to support women’s health across all life stages with a single, integrated system,” said Jihyun Kim, Head of the CX Group at Samsung Medison. “This is more than just a device upgrade — it’s a holistic solution combining clinical expertise and AI-driven innovation to improve outcomes and reduce burdens.”
Addressing High-Risk Pregnancies with Precision Tools
With rising maternal age contributing to an increase in high-risk pregnancies, Samsung Medison is expanding its focus on maternal-fetal health:
- Ophthalmic Artery Doppler Imaging: Now integrated into the system, this feature detects early signs of systemic vasoconstriction, a key indicator of pre-eclampsia. By indirectly monitoring cerebral blood flow via the ophthalmic artery — a branch of the internal carotid artery — clinicians can identify cardiovascular risks earlier than ever before.
- HeartAssist™: Now further enhanced, this tool allows real-time cardiovascular monitoring during pregnancy, offering vital insights into maternal health.
Empowering Clinicians Through AI-Enhanced Efficiency
Samsung Medison continues to prioritize clinical efficiency with new AI-powered tools that simplify complex workflows:
- Live ViewAssist™: Automatically extracts up to 39 key cross-sectional images, complete with annotations and measurements, across different stages of pregnancy — significantly reducing diagnostic time.
- QualityCheck: Evaluates image quality in real time during fetal exams to ensure consistent diagnostic accuracy and reduce the need for repeat scans.
By combining AI technology with real-world clinical workflows, Samsung Medison is driving innovation that matters — delivering smarter, faster, and more comfortable care for women around the world.
